Jump to content
ADVANCED CASE SEARCH
An affiliate of the U.S. Chamber of Commerce
Whether, for purposes of standing under Article III, a plaintiff’s speculation that he might have paid less for treatment if a pharmaceutical product were packaged differently is sufficient to establish an economic injury in fact.
Click here to view the amicus brief filed jointly by the U.S. Chamber, American Tort Reform Association, National Association of Manufacturers, and Pharmaceutical Research and Manufacturers of America.
Jeffrey S. Bucholtz and Paul Alessio Mezzina of King & Spalding LLP served as co-counsel for the amici.